Product Information
EZETIMIBE-SIMVASTATIN 10-20 MG is a generic product labeled by NorthStar Rx LLC, priced at $0.3114 per EA under NDC 16714077902. Its NADAC has been published 330 times since Feb 5, 2020.
FDA first approved this application on Jun 27, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 20 mg/1; mg/1
Manufacturer
NorthStar Rx LLCNDC
16714077902
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA208699FDA Approved
6/27/2019
TE Code
AB
On Market Since
8/19/2019
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE-SIMVASTATIN 10-20 MG has been published 330 times since Feb 5, 2020, and over the history we have for it it has declined 84.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3114 per EA |
|---|---|
| All-time high | $1.9562 (Feb 12, 2020) |
| All-time low | $0.2954 (Dec 17, 2025) |
| 52-week high | $0.4025 |
| 52-week low | $0.2954 |
| Median price | $0.4641 |
| Average price | $0.6527 |
| Largest weekly change | +46.7% (Jun 19, 2024) |
| Weeks tracked | 330 |
| Tracking since | Feb 5, 2020 |
1W
N/A
1M
N/A
3M
0.0%
6M
+0.8%
1Y
-22.6%
3Y
-30.3%
5Y
-66.1%
All
-84.1%
Last surveyed May 27, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-20 MG, manufactured by NorthStar Rx LLC, is $0.3114 per EA (NDC 16714077902), effective May 27, 2026.
How has the price of EZETIMIBE-SIMVASTATIN 10-20 MG changed over time?
Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-20 MG has declined 84.1%. It has been tracked across 330 weekly CMS publications since Feb 5, 2020.
What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-20 MG?
Since Feb 5, 2020, the NADAC for EZETIMIBE-SIMVASTATIN 10-20 MG has ranged from a low of $0.2954 (Dec 17, 2025) to a high of $1.9562 (Feb 12, 2020), with a median of $0.4641 per EA.
Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-20 MG?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-20 MG, is $0.2278 per EA — about 27% below EZETIMIBE-SIMVASTATIN 10-20 MG.
Who manufactures EZETIMIBE-SIMVASTATIN 10-20 MG?
EZETIMIBE-SIMVASTATIN 10-20 MG (NDC 16714077902) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.